Our results demonstrate that while rare, subclonal IDH mutation does occur and appears to have a significantly worse effect on survival compared to grade-matched IDH-mutant astrocytomas with clonal IDH mutation. This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).